title: Epidemiology and outcome of hepatitis C relapse in transplant recipients.
abstract: Hepatitis C virus (HCV)-related end-stage liver disease represents the primary indication for liver transplantation in Western countries, but is associated with poor posttransplantation outcomes and a rapid progression of HCV-related disease. This article reviews the risk factors underlying this association and presents the current strategies used to manage HCV infections in transplant recipients.
authors.affiliation: Dipartimento di Medicina Interna, Università Tor Vergata, Hepatology Unit, Fondazione PoliclinÍco Tor Vergata, Rome, Italy. angelico@med.uniroma2.it
authors.forename: M
authors.initials: M
authors.lastname: Angelico
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D058625:End Stage Liver Disease / Q000175:diagnosis / Q000453:epidemiology / Q000601:surgery* / Q000821:virology; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents